Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Perfectionism and choice deferral in online shopping: a moderated mediation model of fear of missing out and upward social comparison.

Frontiers in psychology·2026
Same author

"Digital eye tracking and plasma biomarkers: Distinguishing functional cognitive impairment from Alzheimer's disease biology".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Creative leadership and kindergarten teachers' creative teaching performance: A moderated mediation model.

Acta psychologica·2026
Same author

Diagnostic and Prognostic Utility of Plasma p-tau217 for Alzheimer's Disease in Chinese Elderly: Insights From the SILCODE Study With a Derived Threshold.

European journal of neurology·2026
Same author

Lamellar Normative Modelling of the Hippocampus Across the Human Lifespan.

bioRxiv : the preprint server for biology·2026
Same author

Linking effort-reward imbalance to work engagement: Job crafting as a mediator and overcommitment as a moderator among rural teachers.

Acta psychologica·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Guoyu Lan1, Laihong Zhang1, Tengfei Guo2

  • 1Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Laboratory, Shenzhen, Guangdong, China.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

化217 (p-tau217) 试验对阿尔茨海默病 (AD) 检测有前景. 中间p-tau217水平表明痴呆风险较高,需要进一步监测早期AD干预.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经学 神经学
  • 生物标志物发现发现
  • 阿尔茨海默氏症疾病研究研究

背景情况:

  • 化tau217 (p-tau217) 是阿尔茨海默病 (AD) 神经病理学的关键生物标志物.
  • 评估商业p-tau217测定对于检测和监测AD进展至关重要.

研究的目的:

  • 调查四个主要商业等离子体p-tau217测定的性能.
  • 评估血p-tau217水平与AD神经病理变化之间的关联,包括Aβ斑块,tau结和海马缩.
  • 评估血p-tau217对认知衰退和痴呆风险的预测值.

主要方法:

  • 分析了来自ADNI队列的363名非痴呆症参与者,使用了四种不同的血p-tau217测定.
  • 根据p-tau217级别将参与者分为负,中间和正组.
  • 粉样斑块 (Aβ-PET),团 (内腔-PET),海马体积和认知表现 (PACC分数) 的纵向评估.

主要成果:

  • 血p-tau217测定有效地确定了AD神经病理学,在测定中介区域百分比的变化.
  • 异常和中间血p-tau217水平与显著的基线异常和Aβ-PET,tau-PET,海马体积和PACC得分的纵向变化相关.
  • 较高的血p-tau217水平,特别是在阳性和中间组中,在平均6.8年的随访期间与痴呆症风险增加有关.

结论:

  • 血p-tau217测定是检测和监测动态阿尔茨海默病进展的宝贵工具.
  • 血p-tau217水平中等的个体需要确认测试和纵向监测,因为痴呆风险较高.
  • 这种方法可以确定早期AD研究和干预的目标人群,从而有可能改善抗粉样蛋白治疗的临床试验查.